PMV Pharmaceuticals, Inc (PMVP) is a publicly traded Healthcare sector company. As of November 10, 2026, PMVP trades at $1.25 with a market cap of $67.36M and a P/E ratio of -1.18. PMVP moved -0.32% today. Year to date, PMVP is +1.22%; over the trailing twelve months it is -4.96%. Its 52-week range spans $0.81 to $1.91. Analyst consensus is strong buy with an average price target of $4.00. Rallies surfaces PMVP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover PMVP: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $4.00.
| Metric | Value |
|---|---|
| Price | $1.25 |
| Market Cap | $67.36M |
| P/E Ratio | -1.18 |
| EPS | $-1.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.91 |
| 52-Week Low | $0.81 |
| Volume | 3.98K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.48M |
| Net Income | $-75.22M |
| Gross Margin | 0.00% |
4 analysts cover PMVP: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.00.